ABSTRACT
Vaccination against human papillomavirus (HPV) is safe and effective. It is recommended for females age 9 to 26 and for males age 11 to 26, yet vaccination rates are low. We review the host immune response, the data behind the recommendations for HPV vaccination, and the challenges of implementing the vaccination program.
Footnotes
↵* Dr. Jin has disclosed that he is on the speakers’ bureau for Merck. Dr. Rome has disclosed that she is on the speakers’ bureau for Merck.
- Copyright © 2013 The Cleveland Clinic Foundation. All Rights Reserved.